387 related articles for article (PubMed ID: 26648062)
1. HPC Analysis of Multiple Binding Sites Communication and Allosteric Modulations in Drug Design: The HSP Case Study.
Chiappori F; Milanesi L; Merelli I
Curr Drug Targets; 2016; 17(14):1610-1625. PubMed ID: 26648062
[TBL] [Abstract][Full Text] [Related]
2. Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design.
Huang W; Nussinov R; Zhang J
Methods Mol Biol; 2017; 1529():439-446. PubMed ID: 27914066
[TBL] [Abstract][Full Text] [Related]
3. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
Bartuzi D; Kaczor AA; Matosiuk D
Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
[TBL] [Abstract][Full Text] [Related]
4. Computational Modeling of the Hsp90 Interactions with Cochaperones and Small-Molecule Inhibitors.
Verkhivker GM
Methods Mol Biol; 2018; 1709():253-273. PubMed ID: 29177665
[TBL] [Abstract][Full Text] [Related]
5. Discovery of hidden allosteric sites as novel targets for allosteric drug design.
Lu S; Ji M; Ni D; Zhang J
Drug Discov Today; 2018 Feb; 23(2):359-365. PubMed ID: 29030241
[TBL] [Abstract][Full Text] [Related]
6. Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs.
Platania CBM; Bucolo C
Methods Mol Biol; 2021; 2253():245-254. PubMed ID: 33315227
[TBL] [Abstract][Full Text] [Related]
7. Understanding G Protein-Coupled Receptor Allostery via Molecular Dynamics Simulations: Implications for Drug Discovery.
Basith S; Lee Y; Choi S
Methods Mol Biol; 2018; 1762():455-472. PubMed ID: 29594786
[TBL] [Abstract][Full Text] [Related]
8. Exploiting protein flexibility to predict the location of allosteric sites.
Panjkovich A; Daura X
BMC Bioinformatics; 2012 Oct; 13():273. PubMed ID: 23095452
[TBL] [Abstract][Full Text] [Related]
9. Predicting Allosteric Effects from Orthosteric Binding in Hsp90-Ligand Interactions: Implications for Fragment-Based Drug Design.
Chandramohan A; Krishnamurthy S; Larsson A; Nordlund P; Jansson A; Anand GS
PLoS Comput Biol; 2016 Jun; 12(6):e1004840. PubMed ID: 27253209
[TBL] [Abstract][Full Text] [Related]
10. Structural dynamics and allostery of Rab proteins: strategies for drug discovery and design.
Kumar AP; Verma CS; Lukman S
Brief Bioinform; 2021 Jan; 22(1):270-287. PubMed ID: 31950981
[TBL] [Abstract][Full Text] [Related]
11. Photoaffinity Labeling of Pentameric Ligand-Gated Ion Channels: A Proteomic Approach to Identify Allosteric Modulator Binding Sites.
Jayakar SS; Ang G; Chiara DC; Hamouda AK
Methods Mol Biol; 2017; 1598():157-197. PubMed ID: 28508361
[TBL] [Abstract][Full Text] [Related]
12. Computational Strategy Revealing the Structural Determinant of Ligand Selectivity towards Highly Similar Protein Targets.
Wang H; Gao Y; Wang J; Cheng M
Curr Drug Targets; 2020; 21(1):76-88. PubMed ID: 31556854
[TBL] [Abstract][Full Text] [Related]
13. Computational allosteric ligand binding site identification on Ras proteins.
McCarthy M; Prakash P; Gorfe AA
Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):3-10. PubMed ID: 26487442
[TBL] [Abstract][Full Text] [Related]
14. Harnessing allostery: a novel approach to drug discovery.
Lu S; Li S; Zhang J
Med Res Rev; 2014 Nov; 34(6):1242-85. PubMed ID: 24827416
[TBL] [Abstract][Full Text] [Related]
15. Designing Molecular Spanners to Throw in the Protein Networks.
Serapian SA; Colombo G
Chemistry; 2020 Apr; 26(21):4656-4670. PubMed ID: 31746512
[TBL] [Abstract][Full Text] [Related]
16. Molecular Dynamics Simulation and Prediction of Druggable Binding Sites.
Feng T; Barakat K
Methods Mol Biol; 2018; 1762():87-103. PubMed ID: 29594769
[TBL] [Abstract][Full Text] [Related]
17. Advances in NMR Methods to Identify Allosteric Sites and Allosteric Ligands.
Abdelkarim H; Hitchinson B; Banerjee A; Gaponenko V
Adv Exp Med Biol; 2019; 1163():171-186. PubMed ID: 31707704
[TBL] [Abstract][Full Text] [Related]
18. Single Binding Pockets Versus Allosteric Binding.
Song K; Zhang J
Methods Mol Biol; 2018; 1825():295-326. PubMed ID: 30334210
[TBL] [Abstract][Full Text] [Related]
19. Are the Apo Proteins Suitable for the Rational Discovery of Allosteric Drugs?
An X; Lu S; Song K; Shen Q; Huang M; Yao X; Liu H; Zhang J
J Chem Inf Model; 2019 Jan; 59(1):597-604. PubMed ID: 30525607
[TBL] [Abstract][Full Text] [Related]
20. Computational approach to de novo discovery of fragment binding for novel protein states.
Konteatis ZD; Klon AE; Zou J; Meshkat S
Methods Enzymol; 2011; 493():357-80. PubMed ID: 21371598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
